Imaging Neural Activity Using Thy1-GCaMP Transgenic Mice von Chen, Qian, Cichon, Joseph, Wang, Wenting, Qiu, Li, Lee, Seok-Jin R., Campbell, Nolan R., DeStefino, Nicholas, Goard, Michael J., Fu, Zhanyan, Yasuda, Ryohei, Looger, Loren L., Arenkiel, Benjamin R., Gan, Wen-Biao, Feng, Guoping

Volltext

Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study von Butzkueven, Helmut, Licata, Stephanie, Jeffery, Douglas, Arnold, Douglas L, Filippi, Massimo, Geurts, Jeroen JG, Santra, Sourav, Campbell, Nolan, Ho, Pei-Ran

Volltext

Chronic lesion activity and disability progression in secondary progressive multiple sclerosis von Beynon, Vanessa, George, Ilena C, Elliott, Colm, Arnold, Douglas L, Ke, Jun, Chen, Huaihou, Zhu, Li, Ke, Chunlei, Giovannoni, Gavin, Scaramozza, Matthew, Campbell, Nolan, Bradley, Daniel P, Franchimont, Nathalie, Gafson, Arie, Belachew, Shibeshih

Volltext

No evidence for loss of natalizumab effectiveness with every-6-week dosing: a propensity score–matched comparison with every-4-week dosing in patients enrolled in the Tysabri Obser... von Butzkueven, Helmut, Kappos, Ludwig, Spelman, Tim, Trojano, Maria, Wiendl, Heinz, Su, Ray, Liao, Shirley, Hyde, Robert, Licata, Stephanie, Ho, Pei-Ran, Campbell, Nolan

Volltext

Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies von Butzkueven, Helmut, Kalincik, Tomas, Patti, Francesco, Slee, Mark, Weinstock-Guttman, Bianca, Buzzard, Katherine, Skibina, Olga, Alroughani, Raed, Prat, Alexandre, Girard, Marc, Horakova, Dana, Havrdova, Eva Kubala, Van der Walt, Anneke, Eichau, Sara, Hyde, Robert, Campbell, Nolan, Bodhinathan, Karthik, Spelman, Tim

Volltext

Natalizumab reduces relapse clinical severity and improves relapse recovery in MS von Lublin, Fred D, Cutter, Gary, Giovannoni, Gavin, Pace, Amy, Campbell, Nolan R, Belachew, Shibeshih

Volltext

Sensor-Derived Measures of Motor and Cognitive Functions in People With Multiple Sclerosis Using Unsupervised Smartphone-Based Assessments: Proof-of-Concept Study von Scaramozza, Matthew, Ruet, Aurélie, Chiesa, Patrizia A, Ahamada, Laïtissia, Bartholomé, Emmanuel, Carment, Loïc, Charre-Morin, Julie, Cosne, Gautier, Diouf, Léa, Guo, Christine C, Juraver, Adrien, Kanzler, Christoph M, Karatsidis, Angelos, Mazzà, Claudia, Penalver-Andres, Joaquin, Ruiz, Marta, Saubusse, Aurore, Simoneau, Gabrielle, Scotland, Alf, Sun, Zhaonan, Tang, Minao, van Beek, Johan, Zajac, Lauren, Belachew, Shibeshih, Brochet, Bruno, Campbell, Nolan

Volltext

Extended-interval dosing of natalizumab in NOVA – Authors' reply von Foley, John F, Campbell, Nolan, Kong, George

Volltext

Nicotinic control of adult-born neuron fate von Campbell, Nolan R., Fernandes, Catarina C., John, Danielle, Lozada, Adrian F., Berg, Darwin K.

Volltext

Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies von Ho, Pei-Ran, Koendgen, Harold, Campbell, Nolan, Haddock, Bill, Richman, Sandra, Chang, Ih

Volltext

Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing von Ryerson, Lana Zhovtis, Foley, John, Chang, Ih, Kister, Ilya, Cutter, Gary, Metzger, Ryan R, Goldberg, Judith D, Li, Xiaochun, Riddle, Evan, Smirnakis, Karen, Kasliwal, Rachna, Ren, Zheng, Hotermans, Christophe, Ho, Pei-Ran, Campbell, Nolan

Volltext

A 2-Stage Model of Heterogenous Treatment Effects for Brain Atrophy in MS Utilizing the MS PATHS Research Network (S27.001) von Hersh, Carrie, Sun, Zhaonan, Grossman, Cynthia, Shen, Changyu, Pellegrini, Fabio, Campbell, Nolan

Volltext

In a Digital Version of the 9-Hole Peg Test, Intra-Task Speed, Accounting for Variance in Distance Traveled, May be a Better Measure of MS-Related Upper-Limb Disability Than Comple... von Jiang, Xiaotong, McGinley, Marisa, Johnston, Joshua, Alberts, Jay, Bermel, Robert, Ontaneda, Daniel, Levitt, Nicholas, Van Beek, Johan, Campbell, Nolan

Volltext

Predicting MRI Changes in Patients with MS in the Absence of Acute Inflammation (P11-3.010) von Tur, Carmen, Sun, Zhaonan, Bradley, Daniel, Grossman, Cynthia, Montalban, Xavier, Rovira, Alex, Tintore, Mar, Campbell, Nolan, Fisher, Elizabeth

Volltext

Endogenous Signaling through α7-Containing Nicotinic Receptors Promotes Maturation and Integration of Adult-Born Neurons in the Hippocampus von Campbell, Nolan R., Fernandes, Catarina C., Halff, Andrew W., Berg, Darwin K.

Volltext

Modeling the Efficacy of Natalizumab in Multiple Sclerosis Patients Who Switch From Every‐4‐Week Dosing to Extended‐Interval Dosing von Chang, Ih, Muralidharan, Kumar Kandadi, Campbell, Nolan, Ho, Pei‐Ran

Volltext

Spatiotemporal characterization of short versus long duration calcium transients in embryonic muscle and their role in myofibrillogenesis von Campbell, Nolan R., Podugu, Sireesha P., Ferrari, Michael B.

Volltext

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlle... von Foley, John F, Defer, Gilles, Ryerson, Lana Zhovtis, Cohen, Jeffrey A, Arnold, Douglas L, Butzkueven, Helmut, Cutter, Gary, Giovannoni, Gavin, Killestein, Joep, Wiendl, Heinz, Smirnakis, Karen, Xiao, Shan, Kong, George, Kuhelj, Robert, Campbell, Nolan, van der Walt, Anneke, Dwyer, Christopher, Buzzard, Katherine, Spies, Judith, Parratt, John, van Pesch, Vincent, Willekens, Barbara, Perrotta, Gaetano, Bartholomé, Emmanuel, Grand'Maison, Francois, Jacques, Francois, Giacomini, Paul, Vosoughi, Reza, Girard, Jean-Marc, de Seze, Jerome, Lebrun Frenay, Christine, Ruet, Aurelie, Laplaud, David-Axel, Reifschneider, Gerd, Wagner, Bert, Rauer, Sebastian, Pul, Refik, Seipelt, Maria, Berthele, Achim, Klotz, Luisa, Kallmann, Boris-Alexander, Paul, Friedemann, Achiron, Anat, Lus, Giacomo, Centonze, Diego, Patti, Francesco, Grimaldi, Luigi, Hupperts, Raymond, Frequin, Stephan, Fermont, Jiske, Madueno, Sara Eichau, Alonso Torres, Ana Maria, Costa-Frossard França, Lucienne, Meca-Lallana, Jose Eustasio, Ruiz, Luis Brieva, Pearson, Owen, Rog, David, Evangelou, Nikolaos, Ismail, Azza, Lathi, Ellen, Fox, Edward, Leist, Thomas, Sloane, Jacob, Wu, Gregory, Khatri, Bhupendra, Steingo, Brian, Thrower, Ben, Gudesblatt, Mark, Calkwood, Jonathan, Bandari, Daniel, Scagnelli, John, Laganke, Christopher, Robertson, Derrick, Kipp, Lucas, Belkin, Martin, Cohan, Stanley, Goldstick, Lawrence, Courtney, Ardith, Vargas, Wendy, Sylvester, Andrew, Srinivasan, Jayshri, Kannan, Meena, Picone, Maryann, English, Jeffrey, Napoli, Salvatore, Balabanov, Roumen, Zaydan, Islam, Nicholas, Jacqueline, Kaplan, Jeffrey, Lublin, Fred, Riser, Emily, Miller, Tamara, Alvarez, Enrique, Wray, Sibyl, Gross, Jeffrey, Pawate, Siddharama, Hersh, Carrie, McCarthy, Lucas, Crayton, Heidi, Graves, Jennifer

Volltext

Serum neurofilament light levels in natalizumab-treated patients with multiple sclerosis who switch to extended interval dosing from every-4-week dosing in real-world clinical prac... von Foley, John, Xiong, Kuangnan, Hoyt, Tammy, Singh, Carol M, Riddle, Evan, de Moor, Carl, Plavina, Tatiana, Campbell, Nolan

Volltext

A digital version of the nine-hole peg test: Speed may be a more reliable measure of upper-limb disability than completion time in patients with multiple sclerosis von Jiang, Xiaotong, McGinley, Marisa, Johnston, Joshua, Alberts, Jay, Bermel, Robert, Ontaneda, Daniel, Naismith, Robert T, Hyde, Robert, Levitt, Nick, van Beek, Johan, Sun, Zhaonan, Campbell, Nolan, Barro, Christian

Volltext